Pseudopeptide inhibitors of Ras farnesyl-protein transferase. 1994

S L Graham, and S J deSolms, and E A Giuliani, and N E Kohl, and S D Mosser, and A I Oliff, and D L Pompliano, and E Rands, and M J Breslin, and A A Deana
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, Pennsylvania 19486.

Inhibitors of Ras farnesyl-protein transferase are described. These are reduced pseudopeptides related to the C-terminal tetrapeptide of the Ras protein that signals farnesylation. Deletion of the carbonyl groups between the first two residues of the tetrapeptides either preserves or improves activity, depending on the peptide sequence. The most potent in vitro enzyme inhibitor described (IC50 = 5 nM) is Cys [psi CH2NH]Ile[psi CH2NH]Phe-Met (3). To obtain compounds able to suppress Ras farnesylation in cell culture, further structural modification to include a homoserine lactone prodrug was required. Compound 18 (Cys[psi CH2NH]Ile[psi CH2NH]Ile-homoserine lactone) reduced the extent of Ras farnesylation by 50% in NIH3T3 fibroblasts in culture at a concentration of 50 microM. Structure-activity studies also led to 12 (Cys[psi CH2NH]Val-Ile-Leu), a potent and selective inhibitor of a related enzyme, the type-I geranylgeranyl protein transferase.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014166 Transferases Transferases are enzymes transferring a group, for example, the methyl group or a glycosyl group, from one compound (generally regarded as donor) to another compound (generally regarded as acceptor). The classification is based on the scheme "donor:acceptor group transferase". (Enzyme Nomenclature, 1992) EC 2. Transferase

Related Publications

S L Graham, and S J deSolms, and E A Giuliani, and N E Kohl, and S D Mosser, and A I Oliff, and D L Pompliano, and E Rands, and M J Breslin, and A A Deana
July 1995, Journal of medicinal chemistry,
S L Graham, and S J deSolms, and E A Giuliani, and N E Kohl, and S D Mosser, and A I Oliff, and D L Pompliano, and E Rands, and M J Breslin, and A A Deana
December 1995, Biochemical and biophysical research communications,
S L Graham, and S J deSolms, and E A Giuliani, and N E Kohl, and S D Mosser, and A I Oliff, and D L Pompliano, and E Rands, and M J Breslin, and A A Deana
January 2000, Critical reviews in oncology/hematology,
S L Graham, and S J deSolms, and E A Giuliani, and N E Kohl, and S D Mosser, and A I Oliff, and D L Pompliano, and E Rands, and M J Breslin, and A A Deana
August 1998, Bioorganic & medicinal chemistry letters,
S L Graham, and S J deSolms, and E A Giuliani, and N E Kohl, and S D Mosser, and A I Oliff, and D L Pompliano, and E Rands, and M J Breslin, and A A Deana
November 1999, IDrugs : the investigational drugs journal,
S L Graham, and S J deSolms, and E A Giuliani, and N E Kohl, and S D Mosser, and A I Oliff, and D L Pompliano, and E Rands, and M J Breslin, and A A Deana
January 1997, Bioorganic & medicinal chemistry,
S L Graham, and S J deSolms, and E A Giuliani, and N E Kohl, and S D Mosser, and A I Oliff, and D L Pompliano, and E Rands, and M J Breslin, and A A Deana
February 1995, Journal of medicinal chemistry,
S L Graham, and S J deSolms, and E A Giuliani, and N E Kohl, and S D Mosser, and A I Oliff, and D L Pompliano, and E Rands, and M J Breslin, and A A Deana
October 1996, Journal of medicinal chemistry,
S L Graham, and S J deSolms, and E A Giuliani, and N E Kohl, and S D Mosser, and A I Oliff, and D L Pompliano, and E Rands, and M J Breslin, and A A Deana
December 2005, Bioorganic & medicinal chemistry letters,
S L Graham, and S J deSolms, and E A Giuliani, and N E Kohl, and S D Mosser, and A I Oliff, and D L Pompliano, and E Rands, and M J Breslin, and A A Deana
March 2001, Anti-cancer drugs,
Copied contents to your clipboard!